Development of a UPLC–MS/MS Method for Determination of Pimavanserin Tartrate in Rat Plasma: Application to a Pharmacokinetic Study
Shixiao Wang,Yang Wang,Shuang Gao,Yuanyuan Zhang,Hanpei Wang,Longshan Zhao,Kaishun Bi,Shaojie Wang,Xiaohui Chen
DOI: https://doi.org/10.1016/j.jpha.2017.07.004
IF: 14.026
2017-01-01
Journal of Pharmaceutical Analysis
Abstract:A simple, rapid and sensitive method based on an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) has been developed and validated for the determination of pimavanserin in rat plasma. The analyte was extracted by protein precipitation with methanol and separated on an ACQUITY BEH C-18 column (100 mm x 2.1 mm, 1.7 mu m; Waters, USA), with an isocratic elution of acetonitrile-water containing 10 mM ammonium acetate (70: 30, v/v), at a flow rate of 0.2 mL/min for 2.5 min. The analyte and clarithromycin (the internal standard) were detected and quantified in positive ion mode using multiple reaction monitoring transitions at m/z 428.2 -> 223.0 for pimavanserin and m/z 748.5 -> 589.5 for clarithromycin. Relative coefficient (r) for the calibration curve was more than 0.9980. The intra-day and inter-day precisions (relative standard deviation, RSD%) were less than 13.3% and 10.5%, respectively, and the accuracy (relative error, RE%) was within +/- 11.5%. The analytical method was successfully applied to a routine pharmacokinetic study of pimavanserin in rats after oral administration at the dose of 10 mg/kg.